ATE347556T1 - Verwendung von kondensierten pyrazolverbindungen für die herstellung eines arzneimittels zur behandlung von bluthochdruck - Google Patents

Verwendung von kondensierten pyrazolverbindungen für die herstellung eines arzneimittels zur behandlung von bluthochdruck

Info

Publication number
ATE347556T1
ATE347556T1 AT03078987T AT03078987T ATE347556T1 AT E347556 T1 ATE347556 T1 AT E347556T1 AT 03078987 T AT03078987 T AT 03078987T AT 03078987 T AT03078987 T AT 03078987T AT E347556 T1 ATE347556 T1 AT E347556T1
Authority
AT
Austria
Prior art keywords
hypertension
treatment
production
medicinal product
pyrazole compounds
Prior art date
Application number
AT03078987T
Other languages
English (en)
Inventor
Sheng-Chu Kuo
Fnag Yu Lee
Che-Ming Teng
Original Assignee
Yung Shin Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yung Shin Pharmaceutical Ind filed Critical Yung Shin Pharmaceutical Ind
Application granted granted Critical
Publication of ATE347556T1 publication Critical patent/ATE347556T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT03078987T 2001-01-24 2002-01-24 Verwendung von kondensierten pyrazolverbindungen für die herstellung eines arzneimittels zur behandlung von bluthochdruck ATE347556T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26378201P 2001-01-24 2001-01-24

Publications (1)

Publication Number Publication Date
ATE347556T1 true ATE347556T1 (de) 2006-12-15

Family

ID=23003205

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03078987T ATE347556T1 (de) 2001-01-24 2002-01-24 Verwendung von kondensierten pyrazolverbindungen für die herstellung eines arzneimittels zur behandlung von bluthochdruck
AT02250490T ATE282622T1 (de) 2001-01-24 2002-01-24 Kondensierte pyrazolverbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02250490T ATE282622T1 (de) 2001-01-24 2002-01-24 Kondensierte pyrazolverbindungen

Country Status (7)

Country Link
US (1) US6518294B2 (de)
EP (1) EP1227099B1 (de)
CN (1) CN1393446B (de)
AT (2) ATE347556T1 (de)
CA (1) CA2369232C (de)
DE (2) DE60201921T2 (de)
TW (1) TWI250161B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077702A1 (en) * 2001-09-14 2004-04-22 Wen-Mei Fu Treatment of nuerodegenerative diseases
US7345079B2 (en) * 2001-12-26 2008-03-18 Yung Shin Pharmaceuticals Industrial Co., Ltd Treatment of disorder related to low cyclic GMP levels
CA2473886C (en) * 2002-01-22 2012-08-21 The Regents Of The University Of California Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
US7166293B2 (en) * 2002-03-29 2007-01-23 Carlsbad Technology, Inc. Angiogenesis inhibitors
US20050096370A1 (en) * 2003-04-07 2005-05-05 Bizbiotech Co., Ltd. Method for inhibiting tumor angiogenesis and tumor growth
JP4499721B2 (ja) 2003-06-30 2010-07-07 ヒフ バイオ，インク． 化合物、組成物および方法
AR046890A1 (es) * 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
GB0405933D0 (en) * 2004-03-16 2004-04-21 Glaxo Group Ltd Compounds
CN100516049C (zh) * 2004-11-16 2009-07-22 永信药品工业股份有限公司 抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成
EP1916896A4 (de) * 2005-08-26 2010-08-11 Univ California Nichtsteroid-antiandrogene
US20080252028A1 (en) * 2007-04-16 2008-10-16 Ming-Tai Huang Shock absorbing device for toy stroller

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 １−（置換ベンジル）−３−（置換アリール）縮合ピラゾール類、その製造法及びその用途
DE19642255A1 (de) 1996-10-14 1998-04-16 Bayer Ag Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten
IT1295384B1 (it) 1997-10-23 1999-05-12 Snam Progetti Rivestimento protettivo di apparecchiature a pressione utilizzabili in processi per la sintesi dell'urea
US6387942B2 (en) 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation

Also Published As

Publication number Publication date
EP1227099A1 (de) 2002-07-31
DE60216610T2 (de) 2007-10-11
EP1227099B1 (de) 2004-11-17
US20030004355A1 (en) 2003-01-02
TWI250161B (en) 2006-03-01
DE60201921T2 (de) 2005-10-06
CN1393446B (zh) 2010-06-16
DE60201921D1 (de) 2004-12-23
CN1393446A (zh) 2003-01-29
HK1050194A1 (zh) 2003-06-13
US6518294B2 (en) 2003-02-11
ATE282622T1 (de) 2004-12-15
CA2369232A1 (en) 2002-07-24
DE60216610D1 (de) 2007-01-18
CA2369232C (en) 2010-05-25

Similar Documents

Publication Publication Date Title
GEP20053421B (en) Substituted Pyrazoles As P38 Kinase Inhibitors, Method for Their Production and Pharmaceutical Compositions Containing Them
NO913750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
MY119118A (en) Thiophenopyrimidines
EA200400432A1 (ru) Производные мочевины
NO20074657L (no) Nitrogenholdige aromatiske ringforbindelser
DE69723869D1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
EP1312601A4 (de) Carbonsäurederivate, verfahren zu deren herstellung und medikamente, die diese als wirkstoff enthalten
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
HUT54279A (en) Herbicidal and bioregulating compositions comprising salicyl-aldehyde and salicylic acid derivatives and their sulfur analogs, as well as process for producing the active ingredients
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
ATE188216T1 (de) Therapeutische mittel für die parkinsonsche krankheit
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
WO2002051819A3 (en) Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
DE60328035D1 (de) Neue azolderivate
YU94103A (sh) Novi derivati sulfonske kiseline
DE60216610D1 (de) Verwendung von kondensierten Pyrazolverbindungen für die Herstellung eines Arzneimittels zur Behandlung von Bluthochdruck
ES2036926A1 (es) "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
HUT57763A (en) Process for producing 2,9-disubstituted-4h-pyrido(1,2-a)pyrimidine-4-one derivatives and pharmaceutical compositions comprising such compounds as active ingredient
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
PT992509E (pt) Novos derivados macrolidos
ATE259376T1 (de) Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren
EP0921122A4 (de) Neue epoxysuccinamid-derivate oder ihre salze
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties